SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marc Kahn who wrote (152)4/19/1998 11:07:00 AM
From: Ron Coby  Read Replies (1) of 534
 
Based on the forward potential developments with Elan,I'd say by year end.His technical calls are 3-12 months.The way bjct trades,which I like,is slow and steady.They'll be at the Regional investment brokers association(r.i.b.a) meetings this week.When these 200 or so brokers hear about the bjct story there going to be impressed in my view.The company is gong to get the story out and the stock to 3 plus to get those warrants converted in my view.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News